Cargando…

Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas

Detalles Bibliográficos
Autores principales:	Wei, Cheng, Wang, Bo, Peng, Dazhao, Zhang, Xiaoyang, Li, Zesheng, Luo, Lin, He, Yingjie, Liang, Hao, Du, Xuezhi, Li, Shenghui, Zhang, Shu, Zhang, Zhenyu, Han, Lei, Zhang, Jianning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261734/ https://www.ncbi.nlm.nih.gov/pubmed/35812444 http://dx.doi.org/10.3389/fimmu.2022.944740

Ejemplares similares

Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas
por: Wei, Cheng, et al.
Publicado: (2022)

A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of ALKBH7
por: Chen, Kaijie, et al.
Publicado: (2022)

LncRNA HOXA11-AS promotes glioma malignant phenotypes and reduces its sensitivity to ROS via Tpl2-MEK1/2-ERK1/2 pathway
por: Wei, Cheng, et al.
Publicado: (2022)

Pan-cancer analysis shows that IBSP is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including osteosarcoma
por: Pan, Boyu, et al.
Publicado: (2023)

Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers
por: Peng, Dazhao, et al.
Publicado: (2021)

Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma
por: Wang, Zhen, et al.
Publicado: (2022)

Pan-cancer analyses reveal the immunotherapeutic value of klotho
por: Liang, Jinghao, et al.
Publicado: (2022)

Pan-cancer analysis supports MAPK12 as a potential prognostic and immunotherapeutic target in multiple tumor types, including in THCA
por: Wang, Jinju, et al.
Publicado: (2022)

Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer
por: Yang, Kaixin, et al.
Publicado: (2022)

CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis
por: Zheng, Xingyu, et al.
Publicado: (2023)

Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of MITD1
por: Dong, Shiqiang, et al.
Publicado: (2022)

Multiomics characteristics and immunotherapeutic potential of EZH2 in pan-cancer
por: Luo, Lianghua, et al.
Publicado: (2023)

Pan-cancer analysis of the PDE4DIP gene with potential prognostic and immunotherapeutic values in multiple cancers including acute myeloid leukemia
por: Li, Qi, et al.
Publicado: (2023)

Comprehensive Pan-Cancer Analyses of Pyroptosis-Related Genes to Predict Survival and Immunotherapeutic Outcome
por: Wang, Qilin, et al.
Publicado: (2022)

Pan-cancer analysis reveals the prognostic and immunotherapeutic value of cytoskeleton-associated protein 2-like
por: Yi, Bocun, et al.
Publicado: (2023)

A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor
por: Mo, Zhuomao, et al.
Publicado: (2021)

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
por: Liu, Weiwei, et al.
Publicado: (2022)

PLK4 initiates crosstalk between cell cycle, cell proliferation and macrophages infiltration in gliomas
por: Zhang, Xiaoyang, et al.
Publicado: (2022)

A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2
por: Wu, Xiaocong, et al.
Publicado: (2023)

Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy
por: Lin, Zhengjun, et al.
Publicado: (2022)

PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
por: Huang, Wei, et al.
Publicado: (2023)

Editorial: The immune escape mechanism and novel immunotherapeutic strategies of leukemia
por: Yu, Kang, et al.
Publicado: (2023)

Potential prognostic and immunotherapeutic value of calponin 1: A pan-cancer analysis
por: Zhou, Hengli, et al.
Publicado: (2023)

PEX13 is a potential immunotherapeutic indicator and prognostic biomarker for various tumors including PAAD
por: Dong, Penggang, et al.
Publicado: (2023)

Pan-Cancer Analysis and Validation of Opioid-Related Receptors Reveals the Immunotherapeutic Value of Toll-Like Receptor 4
por: Wu, Shaoping, et al.
Publicado: (2023)

Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures
por: Wang, Tao, et al.
Publicado: (2023)

Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response [Corrigendum]
Publicado: (2020)

SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer
por: Zhang, Pei, et al.
Publicado: (2023)

Experiences and Expectations for Glioma Immunotherapeutic Approaches
por: Yamanaka, Ryuya, et al.
Publicado: (2014)

Current Immunotherapeutic Approaches for Malignant Gliomas
por: Han, Myung-Hoon, et al.
Publicado: (2022)

The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer
por: Luo, Lin, et al.
Publicado: (2022)

Pan-cancer analysis of IFN-γ with possible immunotherapeutic significance: a verification of single-cell sequencing and bulk omics research
por: Wei, Xiaoying, et al.
Publicado: (2023)

The disordered C terminus of ALKBH5 promotes phase separation and paraspeckles assembly
por: Qin, Xiaoyang, et al.
Publicado: (2023)

RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
por: Qu, Jianwei, et al.
Publicado: (2022)

Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas
por: Huang, Wei, et al.
Publicado: (2023)

Immunotherapeutic Targeting of NG2/CSPG4 in Solid Organ Cancers
por: Zhang, Hongyu, et al.
Publicado: (2022)

Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures
por: Zhang, Xinke, et al.
Publicado: (2021)

FAM46C as a Potential Marker for Pan-Cancer Prognosis and Predicting Immunotherapeutic Efficacy
por: Deng, Jiehua, et al.
Publicado: (2022)

A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of Stanniocalcin-2 (STC2)
por: Jiang, Zhong-Hui, et al.
Publicado: (2022)

Pan‐Cancer analyses of Necroptosis‐Related genes as a potential target to predict immunotherapeutic outcome
por: Zhou, Zheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ktckd6q50720j7u7lhb277f0a3